Haleon PLC Sponsored ADR $HLN Shares Sold by Keystone Financial Planning Inc.

Keystone Financial Planning Inc. cut its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 0.6% in the 2nd quarter, Holdings Channel reports. The firm owned 223,650 shares of the company’s stock after selling 1,269 shares during the period. Haleon makes up approximately 0.7% of Keystone Financial Planning Inc.’s portfolio, making the stock its 26th largest holding. Keystone Financial Planning Inc.’s holdings in Haleon were worth $2,319,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Hanson & Doremus Investment Management lifted its stake in Haleon by 234.1% during the second quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company’s stock valued at $25,000 after purchasing an additional 1,662 shares during the last quarter. Bartlett & CO. Wealth Management LLC lifted its stake in Haleon by 135.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company’s stock valued at $27,000 after purchasing an additional 1,491 shares during the last quarter. Banque Transatlantique SA acquired a new stake in Haleon during the first quarter valued at approximately $27,000. Ransom Advisory Ltd acquired a new stake in Haleon during the first quarter valued at approximately $31,000. Finally, Deutsche Bank AG lifted its stake in Haleon by 267.8% during the first quarter. Deutsche Bank AG now owns 3,126 shares of the company’s stock valued at $32,000 after purchasing an additional 2,276 shares during the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on HLN shares. Barclays cut Haleon from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, September 16th. The Goldman Sachs Group upgraded Haleon from a “neutral” rating to a “buy” rating in a research report on Wednesday, September 10th. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a report on Wednesday, October 8th. Finally, Wall Street Zen cut shares of Haleon from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $12.33.

Haleon Stock Down 1.3%

Haleon stock opened at $9.25 on Friday. The firm has a market cap of $41.17 billion, a price-to-earnings ratio of 23.71, a P/E/G ratio of 2.74 and a beta of 0.20. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.87 and a quick ratio of 0.63. Haleon PLC Sponsored ADR has a fifty-two week low of $8.71 and a fifty-two week high of $11.42. The firm has a fifty day moving average price of $9.38 and a two-hundred day moving average price of $9.98.

Haleon Increases Dividend

The business also recently disclosed a semi-annual dividend, which was paid on Thursday, September 18th. Stockholders of record on Friday, August 15th were given a dividend of $0.0555 per share. This is an increase from Haleon’s previous semi-annual dividend of $0.05. This represents a dividend yield of 190.0%. The ex-dividend date of this dividend was Friday, August 15th. Haleon’s dividend payout ratio (DPR) is currently 28.21%.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.